ADMA Biologics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade ADMA Biologics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ADMA

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. 

CEO
Adam S. Grossman
CEOAdam S. Grossman
Employees
647
Employees647
Headquarters
Ramsey, New Jersey
HeadquartersRamsey, New Jersey
Founded
2004
Founded2004
Employees
647
Employees647

ADMA Key Statistics

Market cap
1.85B
Market cap1.85B
Price-Earnings ratio
11.45
Price-Earnings ratio11.45
Dividend yield
Dividend yield
Average volume
3.35M
Average volume3.35M
High today
$8.14
High today$8.14
Low today
$7.74
Low today$7.74
Open price
$7.83
Open price$7.83
Volume
1.46M
Volume1.46M
52 Week high
$22.37
52 Week high$22.37
52 Week low
$7.21
52 Week low$7.21

Stock Snapshot

With a market cap of 1.85B, ADMA Biologics(ADMA) trades at $7.97. The stock has a price-to-earnings ratio of 11.45.

During the trading session on 2026-06-04, ADMA Biologics(ADMA) shares reached a daily high of $8.14 and a low of $7.74. At a current price of $7.97, the stock is +3.0% higher than the low and still -2.1% under the high.

Trading volume for ADMA Biologics(ADMA) stock has reached 1.46M, versus its average volume of 3.35M.

Over the past 52 weeks, ADMA Biologics(ADMA) stock has traded between a high of $22.37 and a low of $7.21.

Over the past 52 weeks, ADMA Biologics(ADMA) stock has traded between a high of $22.37 and a low of $7.21.

ADMA News

TipRanks 2d
ADMA Biologics Shareholders Back Board, Auditor and Pay

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Simply Wall St 6d
Assessing ADMA Biologics Valuation After A Sharp Multi‑Month Share Price Pullback

Advertisement Recent share performance and business snapshot ADMA Biologics (ADMA) has drawn investor attention after a sharp pullback, with the stock down ab...

Assessing ADMA Biologics Valuation After A Sharp Multi‑Month Share Price Pullback
TipRanks 7d
Insider Makes Bold Move With Fresh ADMA Biologics Buy

New insider activity at ADMA Biologics ( (ADMA) ) has taken place on May 28, 2026. Unlock trusted, data-backed investing tools with TipRanks Premium, from anal...

People also own

Based on the portfolios of people who own ADMA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.